XRCC5 and head and neck squamous cell carcinoma: Further research on the potential of low Ku80 expression as a valid prognostic marker for HNSCC treated with radiotherapy and, if confirmed, on the potential as a predictive marker for PARP-inhibition concomitantly applied with radiotherapy in the frame of personalized medicine concepts in oncology is recommended.